Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 2.7.2024Zentiva, k.s. (ZNT-1)2517DZetovar 10 mg/80 mg tablety (tbl 90x10 mg/80 mg (blis.OPA/Al/PVC))4.7.2024O
 2.7.2024Zentiva, k.s. (ZNT-1)37581Penester (tbl flm 90x5 mg (blis.PVC/PVDC/Al priehľ.))4.7.2024O
 2.7.2024Zentiva, k.s. (ZNT-1)7287CLopridam 4 mg/1,25 mg/10 mg (tbl 30x4 mg/1,25 mg/10 mg (blis.OPA/Al/PVC/Al))4.7.2024O
 2.7.2024Zentiva, k.s. (ZNT-1)7292CLopridam 8 mg/2,5 mg/10 mg (tbl 90x8 mg/2,5 mg/10 mg (blis.OPA/Al/PVC/Al))4.7.2024O
 2.7.2024Zentiva, k.s. (ZNT-1)3113ETeriflunomide Zentiva (tbl flm 28x14 mg (blis.OPA/Al/PVC/Al))1.9.2024U
 1.7.2024STADA Arzneimittel AG (STD)4887EDezmopresín Stada 240 mikrogramov sublingválne tablety (tbl slg 30x240 µg (fľ.HDPE))24.6.2024U
 1.7.2024B.Braun Melsungen AG (BME)0018AParacetamol B. Braun 10 mg/ml (sol inf 10x50 ml/500 mg (fľ.LDPE))1.7.2024O
 1.7.2024Gedeon Richter Plc. (GDN)4988EBOXARID 14 mg filmom obalené tablety (tbl flm 28x14 mg (blis.PA/Al/PVC/Al))1.7.2024U
 1.7.2024Hikma Farmaceutica (Portugal) S.A. (HKP-P)34702MEGAMOX BID 1 g (tbl flm 14x1 g (fľ.HDPE))28.6.2024O
 1.7.2024IPSEN Consumer HealthCare (IAA-2)28225tanakan (tbl flm 90x40 mg (blis.PVC/Al))1.7.2024R
 1.7.2024Grifols Deutschland GmbH (GIO)4986CGamunex (sol inf 1x10 ml (liek.inj.skl.))1.7.2024U
 1.7.2024Grifols Deutschland GmbH (GIO)4990CGamunex (sol inf 1x400 ml (liek.inj.skl.))1.7.2024U
 1.7.2024IPSEN Consumer HealthCare (IAA-2)4999Etanakan (tbl flm 90x40 mg (blis.PVC/Al/PVDC))1.7.2024U
 30.6.2024PIERRE FABRE MEDICAMENT (PFB-FR-1)09783Tardyferon (tbl plg 30x250 mg (blis.Al/PVC/PVDC))1.7.2024O
 30.6.2024PIERRE FABRE MEDICAMENT (PFB-FR-1)98190CYTEAL (sol der 1x250 ml (fľ.HDPE))1.7.2024O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)